Improving Psychodynamic Psychotherapy in Primary Care: Randomised Evaluation of Dynamic Interpersonal Therapy (DIT)
- Conditions
- Topic: Mental Health Research NetworkSubtopic: DepressionMental and Behavioural DisordersDisease: DepressionDepressive episode, unspecified
- Registration Number
- ISRCTN38209986
- Lead Sponsor
- Tavistock and Portman NHS Foundation Trust (UK)
- Brief Summary
2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31084635 (added 21/06/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
1. Aged over 18 years, male or female
2. Current diagnosis of Major depressive disorder (MDD) with or without dysthymic disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria
3. Hamilton Depression Rating Scale score above 14
4. Patient Health Questionnaire (PHQ) score above 10
5. Confirmed need for high-intensity treatment either at triage, following referral, or by low-intensity worker and supervisor
1. Current psychotic symptoms or bipolar disorder
2. Current use of antipsychotic medication
3. Complex Personality Disorder
4. Historic or current self-injury/parasuicide
5. Historic or current eating disorder
6. Current excessive use of drugs/alcohol
7. Non-English speaking
8. Participation in another depression clinical trial within the last year where subject has received CBT
9. Previous unsuccessful CBT treatment
10. Clinical contra-indication to short-term psychotherapy (e.g. attachment history - multiple separations, serious ongoing trauma in childhood, multiple care-givers - suggesting the need for longer term psychotherapy)
11. Evidence of pervasive use of help
12. Highly unstable or insecure life arrangements (e.g. domestic violence)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Primary outcome as of 14/06/2016:<br> Depression severity is measured using a semi-structured interview, the Hamilton Depression Rating Scale (HDRS-17) at baseline, mid-treatment (8 weeks), end-of-treatment (approx. 16 weeks), and long-term follow-ups (52 and 86 weeks).<br><br> Original primary outcome:<br> Hamilton Depression Rating Scale (HDRS-17) at baseline, mid-treatment (8 weeks) end-of-treatment (approx. 16 weeks)<br>
- Secondary Outcome Measures
Name Time Method